Various studies have linked the consumption of energy drinks to a wide range of cardiovascular side effects, including ...

If your blood sugar levels dip too low it may cause a temporary loss of consciousness Here are some immediate steps you ...

Traces of a powerful flesh-eating tranquiliser that turns users into 'zombies' has been found in cocaine and cannabis vapes ...

High blood pressure, or hypertension, is a common condition that affects as many as one in three adults. It can contribute to atherosclerosis (hardening of your arteries) and increase your risk of ...

Request To Download Free Sample of This Strategic Report @ ...

a selective alpha-2 adrenergic receptor agonist. BioXcel Therapeutics believes that BXCL501 potentially targets an important mediator of agitation, and the Company has observed anti-agitation results ...

In these studies, vibegron, as a new beta-3 adrenergic receptor (ß3 AR) agonist, demonstrated a favourable risk-benefit ...

This is the most "strange" season of recent years. Temperatures that already in April reach almost summer peaks, but not only ...

DFUs strike 1.6 million a year in the United States; half develop infections, which can lead to amputation and death. New treatments, new drug trial guidance, and team approach to care may help.

Request To Download Free Sample of This Strategic Report @- Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of ...

Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose (one 8µL spray per eye) Also announces upcoming ARVO ...

Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDANo FDA-approved ...